Law360, New York (October 13, 2009) -- Irish drugmaker Shire PLC said Tuesday it had settled patent litigation over Sandoz Inc.'s abbreviated new drug application to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.
The settlement agreement provides Sandoz with a license to market its own generic versions of Adderall XR in the United States once it receives approval by the U.S. Food and...
